🇺🇸 FDA
Patent

US 8252791

Purine compounds as cannabinoid receptor blockers

granted A61KA61K31/495A61P

Quick answer

US patent 8252791 (Purine compounds as cannabinoid receptor blockers) held by Jenrin Discovery, LLC expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jenrin Discovery, LLC
Grant date
Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/495, A61P, A61P29/00, A61P3/04